Cargando…
Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation
Immune effector cells (IEC) are a powerful and increasingly targeted tool, particularly for the control and eradication of malignant diseases. However, the infusion, expansion, and persistence of autologous or allogeneic IEC or engagement of endogenous immune cells can be associated with significant...
Autores principales: | Baumeister, Susanne H. C., Mohan, Gopi S., Elhaddad, Alaa, Lehmann, Leslie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989409/ https://www.ncbi.nlm.nih.gov/pubmed/35402259 http://dx.doi.org/10.3389/fonc.2022.841117 |
Ejemplares similares
-
Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation
por: Wachter, Franziska, et al.
Publicado: (2023) -
Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
por: Baumeister, Susanne H. C., et al.
Publicado: (2020) -
Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders
por: Mahmoud, Hossam K., et al.
Publicado: (2015) -
Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation
por: D’Amico, Federica, et al.
Publicado: (2019) -
Early vascular toxicity after pediatric allogeneic hematopoietic stem cell transplantation
por: Leimi, Lilli, et al.
Publicado: (2022)